Keyphrases
Primary Care
100%
Spain
45%
Catalonia
42%
Non-valvular Atrial Fibrillation
37%
Electronic Health Records
28%
Confidence Interval
28%
SIDIAP
24%
Population-based Cohort Study
22%
Vitamin K Antagonists
20%
Narcolepsy
20%
Randomized Clinical Trial
20%
Healthcare Electronics
20%
Oral Anticoagulants
20%
Blood Pressure
18%
Stroke Prevention
18%
Dabigatran
16%
Antidepressants
15%
Type 2 Diabetic Patients
15%
Paracetamol
15%
Comorbidity
15%
Placebo
15%
Sweden
15%
Odds Ratio
14%
Nested Case-control Study
14%
Atrial Fibrillation
14%
Molluscum Contagiosum
13%
Potassium Hydroxide
13%
Orphan Medicinal Product
13%
Acute Liver Injury
13%
Population-based
13%
Statin Use
13%
Europe
13%
Catalunya
13%
Electronic Records
13%
COVID-19
13%
Denmark
12%
Hazard Ratio
12%
Moderate to Severe
11%
Clinical Trials
11%
Cardiovascular Risk
11%
Drug Therapy
11%
High Risk
10%
Taiwan
9%
Germany
9%
Pneumonia
9%
Hospital Admission
9%
Statins
9%
Metformin
9%
Peripheral Arterial Disease
9%
ICD-10 Codes
9%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
65%
Atrial Fibrillation
48%
Randomized Clinical Trial
37%
Cerebrovascular Accident
37%
Case-Control Study
36%
Anticoagulant Agent
30%
Placebo
27%
SARS Coronavirus
22%
Cross-Sectional Study
22%
Infection
21%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
20%
Antivitamin K
20%
Narcolepsy
20%
Adverse Event
20%
Non-Steroidal Anti-Inflammatory Drug
19%
Comorbidity
19%
Clinical Trial
18%
Antibiotics
18%
Dabigatran
16%
Antidepressant
16%
Disease
16%
Paracetamol
16%
Pharmacotherapy
14%
Cardiovascular Risk
13%
Acute Coronary Syndrome
13%
Analgesic Agent
13%
Antiplatelet
11%
Coughing
11%
Diseases
11%
Live Attenuated Influenza Vaccine
11%
Acetylsalicylic Acid
11%
Observational Study
10%
Chronic Obstructive Lung Disease
9%
Thromboembolism
9%
Prevalence
9%
Diabetes Mellitus
9%
Peripheral Occlusive Artery Disease
9%
Pandemic
9%
Brain Ischemia
9%
Randomized Controlled Trial
8%
Bleeding
8%
Agomelatine
8%
Influenza A (H1N1)
7%
Cholinergic Receptor Blocking Agent
7%
Bronchitis
7%
Cardiovascular Disease
7%
Non Insulin Dependent Diabetes Mellitus
7%
Apixaban
7%
Direct Oral Anticoagulant
7%
Brain Hemorrhage
7%
Medicine and Dentistry
Primary Health Care
97%
Randomized Clinical Trial
37%
COVID-19
31%
Placebo
30%
Atrial Fibrillation
28%
Cohort Analysis
24%
Apoplexy
22%
Infection
21%
Antithrombotic
20%
Case-Control Study
20%
Electronic Health Record
19%
Severe Acute Respiratory Syndrome Coronavirus 2
18%
Blood Pressure
18%
Cross Sectional Study
18%
Paracetamol
16%
Adverse Event
14%
Narcolepsy
13%
Prevalence
13%
Potassium Hydroxide
13%
Cardiovascular Risk
13%
Molluscum contagiosum
13%
Case-Control Study
13%
Odds Ratio
12%
Drug Therapy
12%
Diabetes
12%
Clinical Trial
12%
Vitamin K Antagonist
11%
Coughing
11%
Health Care Cost
11%
ICD-10
10%
Chronic Obstructive Pulmonary Disease
9%
Thromboembolism
9%
Diabetes Mellitus
9%
General Practitioner
9%
Patient with Type 2 Diabetes
9%
Cohort Study
9%
Glycon
8%
Dabigatran
8%
Randomized Controlled Trial
8%
Logistic Regression Analysis
8%
Malignant Neoplasm
8%
Bronchitis
7%
Parasympatholytic
7%
Apixaban
7%
Rhythm
7%
Chronic Kidney Disease
7%
Cerebral Hemorrhage
7%
Statin
6%
Hazard Ratio
6%
Acetylsalicylic Acid
6%